John Dobak - Mar 7, 2023 Form 4 Insider Report for DermTech, Inc. (DMTK)

Role
Chief Executive Officer, Director
Signature
/s/ Mo Tashakor, attorney-in-fact
Stock symbol
DMTK
Transactions as of
Mar 7, 2023
Transactions value $
-$97,257
Form type
4
Date filed
3/9/2023, 07:17 PM
Previous filing
May 31, 2022
Next filing
Apr 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMTK Common Stock Sale -$2.88K -709 -0.11% $4.06 667K Mar 7, 2023 Direct F1, F2
transaction DMTK Common Stock Sale -$94.4K -23.2K -3.48% $4.06 644K Mar 7, 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 29, 2021.
F2 Includes 5 shares acquired under the Issuer's Employee Stock Purchase Plan on August 31, 2022 and 2,500 shares acquired under the Issuer's Employee Stock Purchase Plan on February 28, 2023.
F3 The shares were sold by the reporting person to generate proceeds used to satisfy the tax withholding obligation that arose upon the vesting of certain restricted stock units granted to the reporting person on March 25, 2022.